Examining the Impact of Blood Flow Restricted Aerobic Exercise on PGC-1α mRNA Expression in Young Healthy Males

NCT ID: NCT03717948

Last Updated: 2019-07-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2018-10-01

Study Completion Date

2019-01-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This crossover study investigates the effects of restricting arterial blood flow during cycling exercise on PGC-1α and its upstream signalling pathways. In a randomized order, participants will exercise once for 30 minutes with restricted blood flow and then will exercise once for 30 minutes with no blood flow restriction.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Mitochondrial Biogenesis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

DOUBLE

Investigators Outcome Assessors
Allocation concealment, assessor blinding

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

CTL - BFR

CTL Exercise then BFR Exercise

Group Type EXPERIMENTAL

BFR Exercise

Intervention Type OTHER

Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).

CTL Exercise

Intervention Type OTHER

Participants will exercise on a recumbent bike placed on flat ground (CTL).

BFR - CTL

BFR Exercise then CTL Exercise

Group Type EXPERIMENTAL

BFR Exercise

Intervention Type OTHER

Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).

CTL Exercise

Intervention Type OTHER

Participants will exercise on a recumbent bike placed on flat ground (CTL).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

BFR Exercise

Participants will exercise on a recumbent bike placed on a 45 degree incline (BFR).

Intervention Type OTHER

CTL Exercise

Participants will exercise on a recumbent bike placed on flat ground (CTL).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 3 hours of physical activity per week
* No previous cycling training
* No concurrent involvement in another training program
* Body mass index \< 30 kg/m2

Exclusion Criteria

* Presence of cardiovascular disease
* Presence of metabolic disease
* Taking regular oral medication
* Current smoker
Minimum Eligible Age

18 Years

Maximum Eligible Age

30 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Queen's University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Brendon Gurd

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Brendon J Gurd, PhD

Role: PRINCIPAL_INVESTIGATOR

Queen's University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Queen's University

Kingston, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

402635

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

BFRNP

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Exercise and Tumor Blood Flow
NCT03987724 UNKNOWN NA